Researchers from The University of Texas MD Anderson Cancer Center identified a new role for heat shock protein 90 (HSP90) in ...
Transcriptomic and protein expression analysis of helicase antigen (HAGE) in triple negative breast cancer (TNBC) as a novel prognostic and predictive biomarker. This is an ASCO Meeting Abstract from ...
Certain genetic mutations can boost your risk of breast cancer. Here’s what experts say you need to know when making the decision to get tested. Possible anomalies in a breast cancer screening are ...
SAN ANTONIO – Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral risk-reducing mastectomy (RRM) and/or a risk-reducing ...
An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...
or on the link below. Olaparib treatment significantly improved objective response rate (primary end point) and progression-free survival versus nonplatinum chemotherapy in patients with BRCA-mutated ...
BRCA1 and BRCA2 are "tumor suppressor genes," meaning that, when normal, they make proteins that keep cells from growing abnormally, according to Cancer.org. "The way I explain it to patients is, they ...
The BRCA gene mutation is most commonly associated with breast cancer. But it can also potentially affect one's risk for other cancers. Here's what to know. Breast cancer has long been on people’s ...
VANESSA THANK YOU. AND NOW TO THE STORY OF A WOMAN WHO IS NOT ONLY A BREAST CANCER ADVOCATE, SHE’S AN AUTHOR AND NOW A MOVIE PRODUCER. HER FIRST FULL LENGTH FILM TACKLES THE DECISIONS A WOMAN WITH A ...
After a breast-cancer diagnosis and a separate scare, my mom tested for the BRCA2 gene mutation. Knowing it could be hereditary, I decided to get tested at 23 to see if I also carried the mutation. My ...
Hosted on MSN
BRCA-mutation carriers with history of early-onset breast cancer may benefit from risk-reducing surgery
Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral risk-reducing mastectomy (RRM) and/or a risk-reducing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results